ORGO (STOCKS)
Organogenesis Holdings Inc. Class A Common Stock
$2.410000
+0.070000 (+2.99%)
Prev close: $2.340000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Gary S. Gillheeney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $309.46M
- Employees
- 869
- P/E (TTM)
- -15.16
- P/B (TTM)
- 1.23
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $514.70M |
| Benefits Costs and Expenses | $510.42M |
| Costs And Expenses | $510.42M |
| Nonoperating Income/Loss | $1.73M |
| Operating Expenses | $512.16M |
| Selling, General, and Administrative Expenses | $318.91M |
| Research and Development | $49.06M |
| Other Operating Expenses | $144.18M |
| Operating Income/Loss | $2.55M |
| Income/Loss From Continuing Operations After Tax | $2.72M |
| Income/Loss From Continuing Operations Before Tax | $4.28M |
| Income Tax Expense/Benefit | $1.56M |
| Income Tax Expense/Benefit, Deferred | -$4.61M |
| Net Income/Loss | $2.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $2.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $18.62M |
| Preferred Stock Dividends And Other Adjustments | $18.62M |
| Basic Earnings Per Share | -$0.15 |
| Diluted Earnings Per Share | -$0.16 |
| Basic Average Shares | 381,591,285 |
| Diluted Average Shares | 396,142,066 |
| Assets | $519.99M |
| Current Assets | $268.50M |
| Inventory | $28.43M |
| Other Current Assets | $240.08M |
| Noncurrent Assets | $251.49M |
| Fixed Assets | $104.08M |
| Intangible Assets | $3.44M |
| Other Non-current Assets | $143.98M |
| Liabilities | $138.65M |
| Current Liabilities | $76.02M |
| Accounts Payable | $28.62M |
| Other Current Liabilities | $47.41M |
| Noncurrent Liabilities | $62.62M |
| Equity | $244.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $244.56M |
| Temporary Equity | $136.79M |
| Temporary Equity Attributable To Parent | $136.79M |
| Liabilities And Equity | $519.99M |
| Net Cash Flow From Operating Activities | $30.75M |
| Net Cash Flow From Operating Activities, Continuing | $30.75M |
| Net Cash Flow From Investing Activities | -$13.67M |
| Net Cash Flow From Investing Activities, Continuing | -$13.67M |
| Net Cash Flow From Financing Activities | -$35.52M |
| Net Cash Flow From Financing Activities, Continuing | -$35.52M |
| Net Cash Flow | -$18.44M |
| Net Cash Flow, Continuing | -$18.44M |
| Comprehensive Income/Loss | $2.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $2.72M |
| Other Comprehensive Income/Loss | $0.00 |